Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jul 23;99(15):9771-6.
doi: 10.1073/pnas.152337399. Epub 2002 Jul 15.

Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties

Affiliations

Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties

Chi H Trinh et al. Proc Natl Acad Sci U S A. .

Abstract

Dissociation of human beta-2-microglobulin (beta(2)m) from the heavy chain of the class I HLA complex is a critical first step in the formation of amyloid fibrils from this protein. As a consequence of renal failure, the concentration of circulating monomeric beta(2)m increases, ultimately leading to deposition of the protein into amyloid fibrils and development of the disorder, dialysis-related amyloidosis. Here we present the crystal structure of a monomeric form of human beta(2)m determined at 1.8-A resolution that reveals remarkable structural changes relative to the HLA-bound protein. These involve the restructuring of a beta bulge that separates two short beta strands to form a new six-residue beta strand at one edge of this beta sandwich protein. These structural changes remove key features proposed to have evolved to protect beta sheet proteins from aggregation [Richardson, J. & Richardson, D. (2002) Proc. Natl. Acad. Sci. USA 99, 2754-2759] and replaces them with an aggregation-competent surface. In combination with solution studies using (1)H NMR, we show that the crystal structure presented here represents a rare species in solution that could provide important clues about the mechanism of amyloid formation from the normally highly soluble native protein.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ribbon diagram of the crystal structures of (a) MHβ2m and (c) HLAβ2m. Detailed views of the conformation of residues 49–68 are also shown for (b) MHβ2m and (d) HLAβ2m. The structure of HLAβ2m was taken from PDB ID code 1DUZ (25). Individual β strands are labeled A although G. a and c were drawn by using the program MOLSCRIPT (37) and RASTER 3D (38) and b and d, by using SPOCK (39).
Figure 2
Figure 2
Topology diagram of the structures of (a) MHβ2m and (b) HLAβ2m showing the location of individual β strands in each structure together with their hydrogen-bonding networks. Solid straight line depicts residues in which both the amide nitrogen and carbonyl oxygen form main-chain–main-chain hydrogen bonds; dotted line, residues that make a main-chain–main-chain hydrogen bond involving either the amide nitrogen or the carbonyl oxygen. Data for b were taken from PDB ID code 1DUZ (25). Strands and hydrogen bonds were determined by using the criteria of Kabsch and Sander (40).
Figure 3
Figure 3
Schematic diagram showing the pattern of NH-NH and CαH-CαH NOEs predicted for conformations of MHβ2m (a) lacking and (b) containing the β bulge involving residues 53 and 54. CαH-CαH region (c) and NH-NH region (d) of a 1H-1H NOESY spectrum of MHβ2m acquired at pH 5.7, 37°C, in D2O and H2O, respectively. Crosspeaks consistent with the presence of the β bulge in solution are marked in bold and underlined. Crosspeaks expected were MHβ2m to adopt a conformation in solution identical to that in a are shown as solid circles.
Figure 4
Figure 4
Ribbon diagram showing the position of His-51 in the crystal structures of (a) MHβ2m and (b) HLAβ2m. Note that in a, His-51 is outwardly pointing, whereas in b, this residue points inward. Drawn by using SPOCK (39).

References

    1. Saper M A, Bjorkman P J, Wiley D C. J Mol Biol. 1991;219:277–319. - PubMed
    1. Floege J, Ehlerding G. Nephron. 1996;72:9–26. - PubMed
    1. Linke R P, Bommer J, Ritz E, Waldherr R, Eulitz M. Biochem Biophys Res Commun. 1986;136:665–671. - PubMed
    1. Bellotti V, Stoppini M, Mangione P, Sunde M, Robinson C, Asti L, Brancaccio D, Ferri G. Eur J Biochem. 1998;258:61–67. - PubMed
    1. Lai Z H, Colon W, Kelly J W. Biochemistry. 1996;35:6470–6482. - PubMed

Publication types

Substances

Associated data